A comprehensive analysis of bone marrow-derived cytogenetic abnormalities in multiple myeloma patients with extramedullary disease
Abstract Background Extramedullary disease (EMD) in multiple myeloma (MM) remains a critical clinical challenge due to its aggressive behavior and resistance to conventional therapies. While cytogenetic abnormalities are recognized contributors to MM progression, their specific roles in EMD pathogen...
Saved in:
| Main Authors: | Juan Xu, Haonan Yang, Jingcao Huang, Ting Niu, Chunyan Sun, Li Zhang, Yuhuan Zheng |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Springer
2025-05-01
|
| Series: | Journal of Cancer Research and Clinical Oncology |
| Subjects: | |
| Online Access: | https://doi.org/10.1007/s00432-025-06223-9 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Expression of Adhesion Molecule CD56 in Tumor Plasma Cells in Bone Marrow as a Prognostic Factor in Multiple Myeloma
by: MV Firsova, et al.
Published: (2019-09-01) -
Subglottic extramedullary plasmacytoma in a patient with multiple myeloma
by: Eva M. Ruis de Gauna Martin, et al.
Published: (2013-03-01) -
Exploring secondary extramedullary myeloma disease: a five-predictor scoring system with spotlight on double-hit cytogenetics
by: Yi Tao, et al.
Published: (2025-05-01) -
Selinexor combined with bortezomib, lenalidomide, and dexamethasone for the treatment of newly diagnosed multiple myeloma with extramedullary disease
by: Junjing Yin, et al.
Published: (2024-11-01) -
Presentation of extramedullary myeloma manifestations on B-mode (B-US) and contrast-enhanced ultrasound (CEUS)
by: Trenker Corinna, et al.
Published: (2025-05-01)